The National Organization for Rare Disorders (NORD)


Database Subscriptions

Many libraries, schools, universities, and hospitals subscribe to NORD’s Rare Disease Database for unlimited access to reports on more than 1,150 diseases.

Index of Rare Diseases

This is the list of diseases currently covered in the Rare Disease Database.

Rare Disease Database

Search this database for reports on more than 1,150 diseases.

View sample report

Index of Organizations

This is the list of organizations in NORD’s Organizational Database.

Organizational Database

Read about more than 2,000 patient organizations and other sources of help.

NORD's
Washington Office

Check here to read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.

 

News Briefs

Gulf War Vets Have Higher Rate of ALS

Preliminary evidence from a large epidemiological study suggests that Gulf War veterans are nearly twice as likely as other veterans to develop the rare disease, amyotrophic lateral sclerosis (ALS), commonly known as "Lou Gehrig's Disease". The one-year study was supported by the U.S. Department of Veterans Affairs and the U.S. Department of Defense.

The preliminary findings, which have not yet been published in a medical journal, were summarized in a December 10, 2001, news release from the Department of Veterans Affairs and may be reviewed on a VA web site (see below).

The study compared the number of veterans who served in Desert Shield-Desert Storm and later were diagnosed with ALS with the number of non-deployed veterans who were diagnosed with ALS during the same period. It does not attempt to explain why the number would be higher among deployed veterans, nor does it show that the increase was necessarily a result of service in the Gulf War. The cause of ALS is unknown (except in a small number of cases that are genetic). Additional research will be needed to determine whether service in the Gulf War actually caused ALS in these veterans, and if so, to identify the exact link between the two.

Among 700,000 veterans deployed to the Persian Gulf, the research team found 40 cases of ALS. The individual risk in that group appeared to be almost twice as high as the individual risk for 1.8 million veterans who did not serve in the Persian Gulf. However, because the number of cases still is small, it is not clear whether there is a link between Gulf War service and ALS.

The study was conducted at the Epidemiologic Research and Information Center at the VA Medical Center in Durham, North Carolina, in cooperation with the Centers for Disease Control and Prevention (CDC) and the Department of Health and Human Services. The ALS Association, based in Calabasas Hills, California, advised the study leaders.

ALS is a neurodegenerative disease that attacks nerve cells in the brain and spinal cord. It results in a progressive loss of muscle function. The cause is not known, and there is no cure. The disease is associated with Lou Gehrig because he retired from baseball after being diagnosed with it, but other famous people, including Senator Jacob Javits, the actor David Niven, and another baseball player, Jim "Catfish" Hunter, also have had ALS.

Based on the results of the study, the Veterans Administration says it will offer disability and survivor benefits to veterans who served in the Persian Gulf during the period August 2, 2990, through July 31, 1991, and later developed Lou Gehrig's Disease.

For more information about the study, click here to visit the Department of Veterans Affairs Epidemiologic Research and Information Center web site.


You may reprint NORD's News Briefs in your newsletter or other publication as long as credit is given to The National Organization for Rare Disorders (NORD), with reference to our web site: www.rarediseases.org.

Enter your e-mail address if you would like to receive "News Blasts" from NORD

ABOUT | CONTACT NORD

Since 1983, working toward the prevention, treatment, and cure of rare “orphan” diseases.

Previous News Briefs

ICORD 2008

FDA and European Union Adopt Shared Form

NORD Representatives Address Congress

CETT Increases Access to Genetic Tests

NORD Honors Innovators at 2007 Tribute Banquet

FDA Approves First Product for PNH

NORD Staff and Rare-Disease Researchers Describe Their Work for Wife of President of Germany

A Common Lesson of Rare Diseases

NORD Issues RFPs

Deadline Announced for Grant Applications

Conference in Korea Focuses on Rare Diseases

FDA Approves Revlimid For Multiple Myeloma

Penn Researchers Pinpoint Cause of FOP

FDA Approves HDE for Rare Disorder of Placenta

CFC Genes Identified With Help of Patient Organization

Saving Andy Martin’s Cells

Haffner Honored by Royal College of Physicians

NORD President Honored For Health Advocacy

NIH Opens New Clinical Research Hospital

Gulf War ALS Study Results Reported

Researchers Identify Progeria Gene

Dystonia Patients Gain Access to "Brain Pacemaker"

Scientists Block CJD-Like Illness in Mice

Genetic Signature Linked to Severe Lupus Symptoms

Genes Linked to Methylmalonic Aciduria Identified

French Researchers Claim a Cure for Severe Sickle Cell

NF1 Research: When a Good Gene Goes Bad

Thalidomide Shows Promise

For Smallpox: Vaccine Production on Target

NORD Member Organization Update August 2002

FDA Approves New "Orphan Drug"

Supreme Court Narrows Disability Law

Dramatic Results Reported in Stiff Person Syndrome Study

Gulf War Vets Have Higher Rate of ALS

Diseases of Bioterrorism

Stay connected!

If you liked these News Briefs, you’ll love our free e-mail News Blasts. You’ll receive breaking news affecting the rare-disease community directly in your inbox if you enter your e-mail address in the box at the top of this page.

ABOUT NORD .|. CONTACT NORD .|. MEMBERSHIP .|. NORD MARKETPLACE .|. PRIVACY POLICY .|. DISCLAIMER .|. HOME
©2006 NORD - National Organization for Rare Disorders, Inc. All rights reserved.

Last modified Friday, March 21, 2008